Arcutis Biotherapeutics, Inc. Liquidation Value
ARQT
Other
Cash & Equivalents
$42.91M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $42.91M
Total Obligations: -$243.36M
$-200.45M
Per share: $-1.63
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $42.91M
AR: $146.23M
Total Obligations: -$243.36M
$-54.22M
Per share: $-0.44
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $42.91M
AR: $146.23M
Inventory: $22.63M
Total Obligations: -$243.36M
$-31.59M
Per share: $-0.26
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-200.45M | $-1.63 |
| Liquid Liquidation Value | $-54.22M | $-0.44 |
| Operating Liquidation Value | $-31.59M | $-0.26 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $42.91M |
| Accounts Receivable | $146.23M |
| Inventory | $22.63M |
| Current Liabilities | $129.84M |
| Long-term Debt | $107.96M |
| Op. Lease Liability | $5.56M |
| Finance Lease | N/A |
| Shares Outstanding | 123.3M |
Explore all 199 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $42.91M | $146.23M | $22.63M | $12.53M | $129.84M | $107.96M | $5.56M | N/A |
| 2025-09-30 | $47.12M | $115.12M | $22.42M | $5.79M | $99.77M | $107.50M | $5.28M | N/A |
| 2025-06-30 | $72.74M | $106.69M | $16.32M | $15.08M | $103.94M | $107.05M | $2.11M | N/A |
| 2025-03-31 | $53.10M | $85.42M | $16.61M | $24.53M | $91.13M | $107.62M | $3.18M | N/A |
▼ Community Notes